Thursday, November 5, 2026

Midland States Bancorp, Inc. And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

January 20, 2021

Midland States Bancorp, Inc. And 3 Other Stocks Have Very High Payout Ratio

We have collected information about stocks with the highest payout ratio up to now. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.

1. Cogent Communications Holdings, Inc.

610.23% Payout Ratio

Cogent Communications Holdings, Inc., through its subsidiaries, provides high-speed Internet access, private network, and data center colocation space services in North America, Europe, Asia, Australia, and Latin America.

As maintained by Morningstar, Inc., the next dividend payment is on Nov 18, 2020, the estimated forward annual dividend rate is 2.92 and the estimated forward annual dividend yield is 4.92%.

Cogent Communications Holdings, Inc.'s sales growth this year is anticipated to be 4% and 3.3% for next year.

Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 549.3M for the twelve trailing months.

Cogent Communications Holdings, Inc.'s sales growth is 2.5% for the current current quarter and 2.9% for the next. The company's growth estimates for the ongoing quarter and the next is 6.3% and 5%.

Volatility

Cogent Communications Holdings, Inc.'s last day, last week, and last month's average volatility was a negative 1.01%, a negative 0.16%, and a positive 0.17%, respectively.

Cogent Communications Holdings, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 3.42%, 4.06%, and 3.62%, respectively.

Cogent Communications Holdings, Inc.'s Stock Yearly Top and Bottom Value

Cogent Communications Holdings, Inc.'s stock is valued at $59.36 at 22:23 EST, way below its 52-week high of $92.96 and way higher than its 52-week low of $53.20.

Cogent Communications Holdings, Inc.'s Moving Average

Cogent Communications Holdings, Inc.'s value is above its 50-day moving average of $58.99 and way under its 200-day moving average of $66.23.

2. Midland States Bancorp, Inc.

95% Payout Ratio

Midland States Bancorp, Inc. operates as a financial holding company for Midland States Bank that provides various banking products and services to individuals, businesses, municipalities, and other entities.

According to Morningstar, Inc., the next dividend payment is on Nov 18, 2020, the estimated forward annual dividend rate is 1.07 and the estimated forward annual dividend yield is 5.22%.

Midland States Bancorp, Inc.'s sales growth this year is anticipated to be 0.1% and a negative 1.8% for next year.

Year-on-year quarterly revenue growth declined by 10.1%, now sitting on 232.22M for the twelve trailing months.

Midland States Bancorp, Inc.'s sales growth is 1.2% for the present current quarter and 20.1% for the next. The company's growth estimates for the ongoing quarter and the next is 24% and 850%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.23%.

Volatility

Midland States Bancorp, Inc.'s last day, last week, and last month's average volatility was 0.90%, 0.49%, and 0.74%, respectively.

Midland States Bancorp, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 1.61%, 3.23%, and 3.44%, respectively.

Midland States Bancorp, Inc.'s Stock Yearly Top and Bottom Value

Midland States Bancorp, Inc.'s stock is valued at $20.09 at 22:23 EST, way below its 52-week high of $29.08 and way higher than its 52-week low of $12.48.

Midland States Bancorp, Inc.'s Moving Average

Midland States Bancorp, Inc.'s value is way above its 50-day moving average of $18.11 and way higher than its 200-day moving average of $15.54.

3. Smith & Nephew SNATS, Inc.

84.08% Payout Ratio

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide.

As stated by Morningstar, Inc., the next dividend payment is on Sep 30, 2020, the estimated forward annual dividend rate is 0.58 and the estimated forward annual dividend yield is 1.31%.

Smith & Nephew SNATS, Inc.'s sales growth this year is anticipated to be negative 0% and a negative 0% for next year.

Year-on-year quarterly revenue growth declined by 18.1%, now sitting on 4.69B for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.89%.

Volatility

Smith & Nephew SNATS, Inc.'s last day, last week, and last month's average volatility was 1.43%, 1.10%, and 0.38%, respectively.

Smith & Nephew SNATS, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 1.85%, 2.76%, and 1.87%, respectively.

Smith & Nephew SNATS, Inc.'s Stock Yearly Top and Bottom Value

Smith & Nephew SNATS, Inc.'s stock is valued at $44.54 at 22:23 EST, way below its 52-week high of $52.26 and way higher than its 52-week low of $26.07.

Smith & Nephew SNATS, Inc.'s Moving Average

Smith & Nephew SNATS, Inc.'s value is higher than its 50-day moving average of $41.23 and way higher than its 200-day moving average of $39.99.

4. Blackrock MuniHoldings Quality Fund, Inc

147.95% Payout Ratio

BlackRock MuniHoldings Quality Fund, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC.

As maintained by Morningstar, Inc., the next dividend payment is on Jan 13, 2021, the estimated forward annual dividend rate is 0.65 and the estimated forward annual dividend yield is 4.94%.

Blackrock MuniHoldings Quality Fund, Inc's sales growth this year is anticipated to be negative 0% and a negative 0% for next year.

Year-on-year quarterly revenue growth declined by 2.2%, now sitting on 11.47M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -2.2%.

Volatility

Blackrock MuniHoldings Quality Fund, Inc's last day, last week, and last month's average volatility was a positive 0.91%, a positive 0.05%, and a negative 0.02%, respectively.

Blackrock MuniHoldings Quality Fund, Inc's last day, last week, and last month's high and low average amplitude percentage was 2.14%, 1.42%, and 0.93%, respectively.

Blackrock MuniHoldings Quality Fund, Inc's Stock Yearly Top and Bottom Value

Blackrock MuniHoldings Quality Fund, Inc's stock is valued at $13.25 at 22:23 EST, under its 52-week high of $13.39 and way above its 52-week low of $9.21.

Blackrock MuniHoldings Quality Fund, Inc's Moving Average

Blackrock MuniHoldings Quality Fund, Inc's worth is above its 50-day moving average of $13.17 and above its 200-day moving average of $12.86.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com